SEC 13F Intelligence

Managers / Q4 2019 · view latest →

Norwest Venture Partners XII, LP

CIK 0001614660 · 525 UNIVERSITY AVENUE, SUITE 800, PALO ALTO, CA, 94301 · 650-321-8000

Reported Value
$102M
Q4 2019
Positions
1
Filings on Record
9
2019–present window
Filed
Feb 4, 2020
original filing

Summary

Norwest Venture Partners Xii, LP reported $102M in U.S.-listed holdings across 1 positions for Q4 2019.

The portfolio is heavily concentrated: HCAT alone accounts for 100.0% of reported value.

Portfolio Metrics

Largest Position
+100.0%
Health Catalyst

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’19: $102MQ4 ’19Q1 ’20: $62MQ1 ’20Q2 ’20: $86MQ2 ’20Q3 ’20: $46MQ3 ’20Q4 ’21: $258MQ4 ’21Q1 ’22: $157MQ1 ’22Q2 ’22: $96MQ2 ’22Q3 ’22: $75MQ3 ’22filingsflow.com

Portfolio Composition

By security type
Common Stock: 100.0%
  • Common Stock · 100.0% · $102M

Quarter-over-Quarter Changes full breakdown →

IssuerMoveShare ΔShares nowValue ΔValue now
HCATHealth Catalyst Inc.NEW+2.95M2.95M+$102M$102M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2019

1 positions
#IssuerClass% PortfolioValueShares
1HCATHealth Catalyst Inc.history →COM100.00%$102M2.95M

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2022$75M2Nov 9, 202213F-HRchanges · EDGAR ↗
Q2 2022$96M2Jul 27, 202213F-HRchanges · EDGAR ↗
Q1 2022$157M2May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$258M3Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2020$46M2Oct 23, 202013F-HRchanges · EDGAR ↗
Q2 2020$86M2Jul 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$62M1Apr 10, 202013F-HRchanges · EDGAR ↗
Q4 2019$102M1Feb 4, 202013F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.